Antares Pharma, Inc.

Report date

3/31/2022

Quarter

2022 Q1

Filed

8/15/2024

5,000

Value ($000)

Weight

0.0%

2017 Q1 - 2022 Q1 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	8/15/2024	21	0.0%	5,000	3/31/2022
2021 Q4	8/30/2024	18	0.0%	5,000	12/31/2021
2021 Q3	8/30/2024	20	0.0%	5,600	9/30/2021
2021 Q2	8/30/2024	24	0.0%	5,600	6/30/2021
2021 Q1	8/30/2024	23	0.0%	5,600	3/31/2021
2020 Q4	8/30/2024	22	0.0%	5,600	12/31/2020
2020 Q3	8/30/2024	15	0.0%	5,600	9/30/2020
2020 Q2	8/30/2024	15	0.0%	5,600	6/30/2020
2020 Q1	8/30/2024	12	0.0%	5,000	3/31/2020
2019 Q4	8/30/2024	24	0.0%	5,000	12/31/2019
2019 Q3	8/30/2024	17	0.0%	5,000	9/30/2019
2019 Q2	8/30/2024	16	0.0%	5,000	6/30/2019
2019 Q1	8/30/2024	15	0.0%	5,000	3/31/2019
2018 Q4	8/30/2024	14	0.0%	5,000	12/31/2018
2018 Q3	8/30/2024	17	0.0%	5,180	9/30/2018
2018 Q2	8/30/2024	13	0.0%	5,180	6/30/2018
2018 Q1	8/30/2024	11	0.0%	5,180	3/31/2018
2017 Q4	8/30/2024	10	0.0%	5,180	12/31/2017
2017 Q3	8/30/2024	17	0.0%	5,180	9/30/2017
2017 Q2	8/30/2024	17	0.0%	5,180	6/30/2017
2017 Q1	8/30/2024	15	0.0%	5,180	3/31/2017